These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7566870)

  • 1. Combined continuous hormone replacement therapy: a critical review.
    Gambrell RD
    Obstet Gynecol; 1995 Nov; 86(5):869-70. PubMed ID: 7566870
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and gynecological cancer.
    Gadducci A; Fanucchi A; Cosio S; Genazzani AR
    Anticancer Res; 1997; 17(5B):3793-8. PubMed ID: 9427782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy, breast and endometrial cancer.
    La Vecchia C
    Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
    Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
    J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement of self-reported use of menopausal hormone replacement therapy with physician reports.
    Jain MG; Rohan TE; Howe GR
    Epidemiology; 1999 May; 10(3):260-3. PubMed ID: 10230835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone-replacement therapy.
    Hilmy N
    N Engl J Med; 2002 Jan; 346(1):63-5. PubMed ID: 11799954
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of estradiol on human endometrial cancer. Experimental in vivo and in vitro studies].
    Horvath G
    Lakartidningen; 2000 May; 97(22):2746-50. PubMed ID: 10900896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postmenopausal hormone replacement under scrutiny. "Fatal therapy"?].
    Braendle W; Semler J
    MMW Fortschr Med; 2000 Aug; 142(33-34):11-2. PubMed ID: 10998894
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone replacement therapy and the endometrium.
    Daayana S; Holland CM
    Menopause Int; 2009 Sep; 15(3):134-8. PubMed ID: 19723685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term postmenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al.
    Odem RR; Moniz MH; Allsworth JE; Bleckman CR; Omicioli VA; Lawrence LT; Thaker PH
    Am J Obstet Gynecol; 2007 Aug; 197(2):213-4; discussion e1-5. PubMed ID: 17689656
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current status: hormone substitution and risk of endometrial carcinoma].
    Kuhl H
    Zentralbl Gynakol; 1997; 119(6):296-7. PubMed ID: 9312968
    [No Abstract]   [Full Text] [Related]  

  • 14. Wanted: more evidence on whether estrogen replacement causes cancer.
    Naftolin F; Rutherford TJ; Chambers JT; Carcangiu ML
    J Soc Gynecol Investig; 1997; 4(2):57. PubMed ID: 9101461
    [No Abstract]   [Full Text] [Related]  

  • 15. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer.
    Reed SD; Voigt LF; Beresford SA; Hill DA; Doherty JA; Weiss NS
    Am J Obstet Gynecol; 2004 Oct; 191(4):1146-51. PubMed ID: 15507934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer.
    Comerci JT; Fields AL; Runowicz CD; Goldberg GL
    Gynecol Oncol; 1997 Mar; 64(3):425-30. PubMed ID: 9062144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualising hormone replacement therapy.
    Attilakos G; Wardle PG
    Practitioner; 2002 May; 246(1634):295-8, 302, 305 passim. PubMed ID: 12043347
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis.
    Horn LC; Dietel M; Einenkel J
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):4-12. PubMed ID: 15927347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
    Gibbons WE; Thorneycroft IH
    J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.